Michelson Medical Research Foundation Inc. Buys Shares of 180,000 Rentokil Initial plc (NYSE:RTO)

Michelson Medical Research Foundation Inc. purchased a new position in Rentokil Initial plc (NYSE:RTOFree Report) in the 3rd quarter, HoldingsChannel reports. The institutional investor purchased 180,000 shares of the company’s stock, valued at approximately $4,487,000. Rentokil Initial comprises approximately 3.2% of Michelson Medical Research Foundation Inc.’s investment portfolio, making the stock its 12th biggest position.

A number of other hedge funds have also recently made changes to their positions in the stock. Rothschild Investment LLC purchased a new position in Rentokil Initial in the second quarter worth $29,000. Valley Wealth Managers Inc. acquired a new stake in shares of Rentokil Initial in the 3rd quarter worth $29,000. Northwestern Mutual Wealth Management Co. increased its position in Rentokil Initial by 403.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,052 shares of the company’s stock valued at $31,000 after buying an additional 843 shares in the last quarter. Assetmark Inc. acquired a new position in Rentokil Initial during the 3rd quarter valued at about $36,000. Finally, GPS Wealth Strategies Group LLC purchased a new stake in Rentokil Initial in the second quarter valued at about $38,000. 9.91% of the stock is currently owned by hedge funds and other institutional investors.

Rentokil Initial Stock Performance

Shares of RTO stock opened at $25.82 on Wednesday. The business has a fifty day moving average of $25.17 and a 200 day moving average of $27.87. Rentokil Initial plc has a 1 year low of $22.40 and a 1 year high of $34.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04.

Wall Street Analyst Weigh In

Separately, Redburn Atlantic downgraded shares of Rentokil Initial from a “buy” rating to a “neutral” rating in a report on Thursday, September 19th. Five research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $29.00.

Check Out Our Latest Research Report on Rentokil Initial

Rentokil Initial Company Profile

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Stories

Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial plc (NYSE:RTOFree Report).

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.